Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to 33.27%.

  • Lemaitre Vascular's EBITDA Margin rose 92900.0% to 33.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.71%, marking a year-over-year increase of 24300.0%. This contributed to the annual value of 23.77% for FY2024, which is 47900.0% up from last year.
  • According to the latest figures from Q3 2025, Lemaitre Vascular's EBITDA Margin is 33.27%, which was up 92900.0% from 25.13% recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's EBITDA Margin registered a high of 33.27% during Q3 2025, and its lowest value of 13.74% during Q2 2022.
  • Over the past 5 years, Lemaitre Vascular's median EBITDA Margin value was 21.09% (recorded in 2025), while the average stood at 21.63%.
  • In the last 5 years, Lemaitre Vascular's EBITDA Margin plummeted by -135700bps in 2022 and then soared by 92900bps in 2025.
  • Lemaitre Vascular's EBITDA Margin (Quarter) stood at 21.01% in 2021, then dropped by -19bps to 17.01% in 2022, then increased by 23bps to 20.88% in 2023, then grew by 10bps to 23.07% in 2024, then soared by 44bps to 33.27% in 2025.
  • Its EBITDA Margin stands at 33.27% for Q3 2025, versus 25.13% for Q2 2025 and 21.09% for Q1 2025.